Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC announces that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for Aminocaproic Acid Tablets USP, 500 mg, a generic version of Amicar®* tablets, 500mg. Aminocaproic Acid Tablets USP, 500 mg, are useful in enhancing hemostasis when fibrinolysis contributes to bleeding. For more information please contact the Company directly at info@dexcelpharmausa.com.
Aminocaproic Acid Tablets, USP Approval
Specialty Products
To learn more about our specialty products, vigabatrin and Yargesa®, and how you may be able to save, please visit the Products page or navigate to a product-specific page.
Specialty Products
To learn more about our specialty products, vigabatrin and Yargesa®, and how you may be able to save, please visit the Products page or navigate to a product-specific page.